Connor, Clark & Lunn Investment Management (CC&L)’s Ironwood Pharmaceuticals IRWD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.58M | Buy |
2,206,948
+718,904
| +48% | +$516K | 0.01% | 926 |
|
|
2025
Q1 | $2.19M | Buy |
1,488,044
+1,146,589
| +336% | +$1.69M | 0.01% | 706 |
|
|
2024
Q4 | $1.51M | Buy |
341,455
+215,166
| +170% | +$953K | 0.01% | 804 |
|
|
2024
Q3 | $520K | Buy |
126,289
+75,917
| +151% | +$313K | ﹤0.01% | 1088 |
|
|
2024
Q2 | $328K | Buy |
+50,372
| New | +$328K | ﹤0.01% | 1160 |
|
|
2024
Q1 | – | Sell |
-303,675
| Closed | -$3.47M | – | 1612 |
|
|
2023
Q4 | $3.47M | Sell |
303,675
-197,006
| -39% | -$2.25M | 0.02% | 525 |
|
|
2023
Q3 | $4.82M | Sell |
500,681
-136
| -0% | -$1.31K | 0.03% | 409 |
|
|
2023
Q2 | $5.33M | Buy |
500,817
+8,293
| +2% | +$88.2K | 0.03% | 385 |
|
|
2023
Q1 | $5.18M | Buy |
492,524
+189,959
| +63% | +$2M | 0.03% | 361 |
|
|
2022
Q4 | $3.75M | Buy |
+302,565
| New | +$3.75M | 0.02% | 415 |
|
|
2019
Q4 | – | Sell |
-59,175
| Closed | -$508K | – | 1011 |
|
|
2019
Q3 | $508K | Buy |
+59,175
| New | +$508K | ﹤0.01% | 677 |
|
|
2016
Q1 | – | Sell |
-48,238
| Closed | -$468K | – | 870 |
|
|
2015
Q4 | $468K | Buy |
48,238
+1,433
| +3% | +$13.9K | ﹤0.01% | 553 |
|
|
2015
Q3 | $408K | Buy |
+46,805
| New | +$408K | ﹤0.01% | 556 |
|